Skip to content

Randomised, controlled, double-blind clinical study on the effect of a functional milk-product on metabolism of men with diagnosed metabolic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN41474531
Enrollment
60
Registered
2007-04-30
Start date
2007-02-05
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome Nutritional, Metabolic, Endocrine Metabolic syndrome

Interventions

Sponsors

Humana GmbH (Germany)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Men, 45-70 years old, with a metabolic syndrome as defined by the International Diabetes Federation, 2006 (A new IDF worldwide definition of the metabolic syndrome: the rationale and the results - Diabetes Voice, Vol. 50 Issue 3, 2005)

Exclusion criteria

Exclusion criteria: 1. Participation in a clinical study with a medicament or a medicinal product within the last 30 days or simultaneous participation in another clinical examination 2. Intake of nitrate and/or calcium antagonists and/or alpha-blockers, which affect the blood pressure 3. Known metabolic or gastro-intestinal diseases, which affects the absorption, metabolism or excretion of food or food component 4. Condition after operation of the gastro-intestinal tract, which affect gastro-intestinal motility 5. Hemoglobin < 12 g/dL 6. Malfunction of blood coagulation or drugs, leading to malfunction of blood coagulating diabetes 7. Operation within the last 3 months, which still affects the current state of health 8. Illness of thyroid gland, which has metabolic and/or cardiovascular effect 9. Known hepatitis B, hepatitis C, HIV infection or chronic liver damage 10. Kidney insufficiency 11. Hypercalcaemia 12. Drug or alcohol abuse 13. Intake of drugs affecting the absorption, metabolism or excretion of food components or the gastro-intestinal 14. Intake of hormone preparations 15. Vegetarianism, anorexia, bulimia 16. Known milk protein allergy

Design outcomes

Primary

MeasureTime frame
Change of blood fructosamine concentration during the intervention period

Secondary

MeasureTime frame
1. Insulin sensitivity 2. Endothelial function 3. Blood pressure 4. Waist-to-hip ratio 5. Postprandial concentration of several hormones and blood parameters linked to fat and carbohydrate metabolism

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026